Croda International Plc (LON:CRDA – Get Free Report) insider Tom Brophy sold 1,020 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of GBX 2,652, for a total transaction of £27,050.40.
Croda International Stock Down 1.1%
Shares of LON:CRDA traded down GBX 29 during midday trading on Wednesday, reaching GBX 2,623. The company’s stock had a trading volume of 2,682,474 shares, compared to its average volume of 3,776,576. The company has a quick ratio of 2.25, a current ratio of 1.99 and a debt-to-equity ratio of 34.76. The firm has a 50 day moving average of GBX 2,849.49 and a 200-day moving average of GBX 2,773.79. The firm has a market capitalization of £3.66 billion, a P/E ratio of 59.08, a PEG ratio of 1.40 and a beta of 0.96. Croda International Plc has a 12-month low of GBX 2,426.77 and a 12-month high of GBX 3,312.
Croda International (LON:CRDA – Get Free Report) last issued its quarterly earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 3.65% and a return on equity of 2.82%. On average, research analysts anticipate that Croda International Plc will post 181.8307268 earnings per share for the current year.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Read More
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
